FDA Import Refusal SCS-9427835-6/11/1 — SIGNATURE PHARMACEUTICAL
The FDA refused shipment SCS-9427835-6/11/1 from SIGNATURE PHARMACEUTICAL (India) on Apr 28, 2020. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charge: 75 This firm has 1 other import refusal on record.
Refusal details
- Date
- Apr 28, 2020
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 66VCA99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 75